Patents by Inventor Mehdi Mirsaeidi

Mehdi Mirsaeidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230126533
    Abstract: The present disclosure is directed to a method of treating an inflammatory disorder, such as sarcoidosis, using a growth hormone-releasing hormone (GHRH) antagonist.
    Type: Application
    Filed: October 27, 2022
    Publication date: April 27, 2023
    Inventors: Mehdi Mirsaeidi, Chongxu Zhang, Andrew V. Schally, Renzhi Cai, Runxia Tian
  • Publication number: 20220361461
    Abstract: The disclosure relates to a sarcoidosis animal model and methods of inducing sarcoidosis in an animal. The disclosure also relates to methods of producing an in vitro granuloma, and methods of using the sarcoidosis animal model. Disclosed herein are animals comprising one or more granulomas, wherein the one or more granulomas comprise Mycobacterium abscessus cell wall microparticles.
    Type: Application
    Filed: June 26, 2020
    Publication date: November 17, 2022
    Inventors: Mehdi Mirsaeidi, Chongxu Zhang
  • Publication number: 20220143149
    Abstract: The disclosure provides a method of treating sarcoidosis, the method comprising administering a GHRH antagonist to mammalian subject in need thereof.
    Type: Application
    Filed: January 17, 2022
    Publication date: May 12, 2022
    Inventors: Mehdi Mirsaeidi, Chongxu Zhang, Andrew V. Schally, Renzhi Cai